Skip to main content
Download PDF
- Main
Apparent darkening of scalp hair related to pili multigemini Following dabrafenib and trametinib
© 2020 by the author(s). Learn more.
Abstract
The combination of dabrafenib and trametinib is an important immunotherapy option for patients with BRAF V600 mutation-positive melanoma. This regimen has been reported to cause cutaneous eruptions. However, hair dysmorphology is not a reported side effect to these or any other medications to date. Herein, we highlight a case of pili multigemini formation in a patient with stage IV melanoma receiving treatment with dabrafenib and trametinib and the corresponding clinical findings.